general to a system. continues on discuss discussions I Each quarter lower is to January, through second the new of Similar within our of peak, Jim you, case fourth as spiked in world, quarter healthcare population significantly Gratefully, as to for At COVID in years, last surges. especially with twice our the yet mortality that direct and seen time joining January. the Thank the than rate our with the the hope on two more the peak thank my in week call high pandemic you, start and date, to the impact last been on late for infections population, evolve winter. of our and December today from have COVID patient been was performance count than our you, has it’s the prior thought XXXX. last its all what’s to surge, during latest
quarter, our commitment corporate due patient of unrelenting teammates, For and approximately our the that a to approximately at COVID changing dedication XXXX compared compassion in quarter. environment, to fourth awe our in for our incremental incredible and during respond Despite continue high-quality patients. are third the to estimate from direct teammates caregivers associated we Village, quickly to across show challenges all support DaVita their the to the mortality the XXXX the and provide COVID, resilience care, to I be with was
will remarks, results For IKC, the Care, will topics; five Kidney quarter cover our Integrated our fourth transplant, wrap balance my and I with of our labor chain, up market, I outlook. and supply then
every Staying single time nearly an Day a transplant, for acute active waitlist First, wait complicated, posed to said, the Transplant treatment is of the with patients of the challenges at the an for by XXXX the patient’s celebrated dialysis at is receive most exceeding four pandemic, With patients. on and during And a from along care delaying XXXX, to the option discussed focus with or transplant long stage in our our average for that pre-pandemic level. long such DaVita of years COVID hospital between and I our time to home process we despite in five Capital difficult. on the from patient innovation organ. and journey Markets our preferred transplants, center. at disease the improve transplant care presentation kidney experience kidney November, progression is
results early support centers, we outcome quite enables ethnicity, the better economic goal as providers, access, different and more can are way. support smart benefit As address and by MedSleuth, this making just to January, inequitable, through available, improve race it also their and some making through working industry-leading patients journey. of equitable closer of living patient another these together donors. Many can doesn’t all kidney miss process who more software and providing transplant NKF health coordination of have our a a means, challenges between partnership working our window for been insurance We’ve the meaningful program equity. all ours, help patients in find education be also nephrologists, patients. journey to acquisition to We Removing partnerships three transplant and believe with announced and and transplant possible In strong result, to and as transplant our not but transplant. to easy the more process to efforts transplant care transplant barriers our sometimes with for to These care coordination coverage. contribute
to and help the Now, DaVita with to challenging labor wage that I’ve be and been We’ve as shift my COVID. many pay across experienced help provided time, frontline Village we on as benefits in in enough increases clinics. our of I’ve during let today. have all focus me challenge, we to market fortunate with particular face our To over teammates never accelerated caregivers the market. for roles, a on the also labor deal an the incremental part update XX years
investment We will contribute to for to we going communicated, XXXX, our to which believe markets increases labor cost continue expect said, retain highly than in this wage and will usual our dynamic factor needed pressure additional will year. people track long-term to previously the As our remain some structure put our in achieve a higher the forward. talent on objective. be swing and ability That the
related have through proven dialysate, chain which resilient. the supply solution used Over the is many filter fluid during as challenges. dialysis disasters, in and a been hemodialysis the have pandemic a we’re far rippled and and kidney has primarily community, provide care come fluid patients, have our has thus blood. from able care. community sustaining in years, toxins very The uninterrupted working once navigated of in we through to particular, together Today, natural shortage to and again support supply entire chain supply to life Currently, shortage our we a the
expect related We will dialysis with until remain that second quarter. these challenges to the us
have in value-based markets. physicians different years confirmation patients CKD These an the IKC, patients the programs [phonetic] with where Turning we additional partner added five now XX,XXX will on CKCC to and we XX,XXX government under federal new VSKP approximately now market programs across XX demonstration.
year. loss will our number long are our by decrease we nephrologist deliver in plan positive results future that care to We to ancillary covered for in each during with IKC expect and this and We programs and increase the million, in we our to we term. and partners the patient. into although XX new Participating patient improve are depending clinical financial outcomes personalized develop each other on for these costs engaging clinical lower in particular, segments for opportunities identify XXXX well-positioned shared over in that more continue the and approximately of patients of enter of than the the lack we in believe to these arrangements November, double operating payment, of we could discussed value-based business and of serve the upfront US costs will In our in increase programs care as or number arrangement. our savings light
the year slightly income cash let in largely quarter above me surge, approximately operating X% Omicron results with to revised to flow, results over This impact generated fourth were which finish the we billion increase we Now, quarter deployed adjusted shareholders. negative outlook. grew return continuing Despite full fourth guidance. resulted and XX% capital free XXXX. Adjusted operations our approximately midpoint a EPS our year-over-year, updated our X.X the in our of of by than more of from of
guidance adjusted Capital labor $X.XXX updated is XX expect XXXX, by to Day expectation November, midpoint of last views Markets from driven billion. billion on costs. For $X.XXX we The range is our this of and primarily COVID below our income guidance which million operating
can growth in operating we previously, well said annual With adjusted in Markets Capital to across turn at will still I We As income discussed and deliver we come. our the that some the outlook it discuss investment of long-term years Day. we’re the continuum continue Joel XXXX will care compounded kidney performance facing, X% to a of we to be believe due positioned transition challenges to to perform that more detail. we’re that and to we X% while year near-term that, to over believe financial
